![Nuket Desem](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nuket Desem worked as a Senior Manager of Development & Regulatory Affairs at Alterity Therapeutics Ltd., Vice President of Clinical & Regulatory Affairs at Spinifex Pharmaceuticals Pty Ltd., Principal at CSL Ltd., Senior Associate at Kendle Pty Ltd., Development Director at Percheron Therapeutics Ltd., and Director of Clinical & Regulatory Affairs at Percheron Therapeutics Ltd. and Paranta Biosciences Ltd. Desem holds an MBA from Monash University and an undergraduate degree from LaTrobe University.
Tidigare kända positioner av Nuket Desem
| Företag | Position | Slut |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2023-05-05 |
| PERCHERON THERAPEUTICS LIMITED | Företagsledare/Principal | 2010-08-31 |
| ALTERITY THERAPEUTICS LIMITED | Generell Rådgivare | - |
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Teknisk/Vetenskaplig/F&U Direktör | - |
| CSL LIMITED | Företagsledare/Principal | - |
Nuket Desems utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
3
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Kendle Pty Ltd. | |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
